How we produce intelligence you can rely on for a regulatory submission.

Intelligence begins where regulators and clinicians publish: FDA dockets and label revisions, EMA scientific assessments, ClinicalTrials.gov registry updates, USPTO filings, NICE technology appraisals, ChEMBL bioactivity releases. We connect to each source directly via documented public endpoints and licensed feeds, not through an aggregator that adds a layer of editorial translation between the regulator and you.

Records are continuously refreshed. When a label changes on a Wednesday afternoon, the change is reflected in our knowledge base within hours, not in next quarter's database update.

• Every retrieved record carries source identifier, URL, and UTC retrieval timestamp.
• No silent fallbacks: when a source is unavailable, the absence is logged and surfaced, not hidden.
• Licensed terminologies (MeSH, MedDRA, ICD-10, ATC) are normalized at ingest, not at report time.

Once data is in place, analytical workflows decompose your question into discrete, recorded steps: identify comparator products, retrieve their approval pathways, locate matched clinical evidence, surface label or payer-decision differences. Each step is logged with its inputs, outputs, and the source records it relied on, so a reviewer can re-walk the chain.

We attach a confidence tier to every claim — high, standard, heuristic, or degraded — and the tier is earned from the underlying evidence. Confidence is never inflated to make a report look more decisive than it is.

• Workflows are versioned. The version that produced your report is recorded in the deliverable.
• Therapeutic-area logic is explicit, not embedded in opaque prompts.
• When evidence is thin, the report says so. Silence on weak claims is not an option.

Nothing is delivered to a customer without a named expert reviewing the output. For high-risk claims — regulatory pathway calls, label-change implications, comparative-effectiveness statements — a senior reviewer checks the underlying citations, the analytical reasoning, and the language used to communicate uncertainty.

The reviewer's identity, sign-off timestamp, and any margin notes are preserved as part of the deliverable's audit record. A timed-out review blocks delivery; it never auto-approves silently. This is how we keep our outputs aligned with IEC 62304 Class B expectations.

• Reviewer credentials and review depth are recorded against each claim.
• Conflicts and disagreements are written into the report, not redacted.
• Where a question exceeds in-house expertise, an external subject-matter advisor signs off.

Reports are delivered as fully cited documents. Every claim — including tabular figures and graphical summaries — links to the primary source that supports it, with the retrieval timestamp visible. If a regulator or counsel asks where a number came from, the answer is one click away.

The deliverable is hash-sealed at issuance. Any subsequent revision is added as a new version, never as a silent edit, and the change history travels with the document. The full audit trail — sources, workflow versions, reviewer sign-offs — is available on request for diligence and submissions.

• PDFs and HTML deliverables carry the same citation graph; nothing is lost in export.
• Revisions are versioned, never overwritten. Soft-delete is forbidden.
• Audit packages are exportable for IND/NDA, MAA, and HTA dossiers.